The team analyzed data from 20 people, 10 of whom were slated to receive increasing drug doses over 19 days
Regina Castro of the Mayo Clinic wrote in an article for the institution's website that it is not yet certain why GLP-1 agonists help with weight loss, but they do curb hunger and can make a person eat less
The Nrf2-Keap1 pathway is important in protecting against oxidative stress and inflammation
1 The most recent clinical trial, SURMOUNT-1, reports that the average weight loss among over 2500 trial participants was 16% at 72 weeks
Yamada, Y., Katagiri, H., Hamamoto, Y., Deenadayalan, S., Navarria, A., Nishijima, K., Seino, Y., & PIONEER 10 Investigators
mijewski, M